{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:04:55Z","timestamp":1793747095637,"version":"4.6.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016304","name":"Medtronic","doi-asserted-by":"publisher","award":["IIS ERP-2020-12253"],"award-info":[{"award-number":["IIS ERP-2020-12253"]}],"id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To investigate the relationship between continuously monitored atrial fibrillation (AF) burden after cryoballoon ablation (CBA) and improvements in AF-related symptoms, quality of life (QoL), and AF-related healthcare resource utilization (HCRU) in early persistent AF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This secondary analysis of the multicentre COOL-PER trial included patients with early persistent AF who underwent CBA and continuous monitoring via an implantable loop recorder. Post-CBA AF burden was defined as the percentage of time in AF between 9- and 12-month after CBA, categorized as &amp;lt;0.1%, 0.1 to &amp;lt;10%, and \u226510%. Symptom improvement was assessed using the European Heart Rhythm Association symptom score and QoL with the SF-36 survey. AF-related HCRU was defined as rhythm control interventions after the 90-day blanking period and cardiovascular-related hospitalizations or emergency room visits. Among 130 patients (mean baseline AF burden 77 \u00b1 34%), AF burden significantly decreased post-CBA, with 50.0% achieving &amp;lt;0.1%, 28.5% in 0.1 to &amp;lt;10%, and 21.5% \u2265 10%. Symptom improvement rate was highest in the &amp;lt;0.1% group (89.2%), followed by the 0.1 to &amp;lt;10% (78.4%) and \u226510% (46.4%) groups (P &amp;lt; 0.001). Significant QoL improvement was observed in the &amp;lt;0.1% and 0.1 to &amp;lt;10% groups but not in the \u226510% group. Rhythm control interventions and cardiovascular-related hospitalizations or emergency room visits were more frequent in the \u226510% group (29%, 43%) than in the 0.1 to &amp;lt;10% (5.4%, 22%) and &amp;lt;0.1% (1.5%, 7.7%) groups (both P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In early persistent AF, lower AF burden 1-year post-CBA was associated with greater AF-related symptom improvement, significant QoL enhancement, and reduced HCRU during follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euaf150","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T11:53:49Z","timestamp":1755777229000},"source":"Crossref","is-referenced-by-count":8,"title":["Atrial fibrillation burden and symptom, quality of life, and healthcare resource utilization after cryoballoon ablation in persistent atrial fibrillation"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0751-2407","authenticated-orcid":false,"given":"Muhan","family":"Yeo","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-5015","authenticated-orcid":false,"given":"So-Ryoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4633-640X","authenticated-orcid":false,"given":"JungMin","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-6130","authenticated-orcid":false,"given":"Kyung-Yeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-0378","authenticated-orcid":false,"given":"Hyo-Jeong","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4791-6855","authenticated-orcid":false,"given":"Soonil","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SMG-SNU Boramae Medical Center , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7162-1248","authenticated-orcid":false,"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital , Seongnam ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-3713","authenticated-orcid":false,"given":"Youngjin","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital , Seongnam ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5584-605X","authenticated-orcid":false,"given":"Il-Young","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital , Seongnam ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8102-8352","authenticated-orcid":false,"given":"Hong-Euy","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine , Gwangmyeong-si ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-4991","authenticated-orcid":false,"given":"Min-Soo","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-5406","authenticated-orcid":false,"given":"Gi-Byoung","family":"Nam","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2504-9615","authenticated-orcid":false,"given":"Seil","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1025-7283","authenticated-orcid":false,"given":"Young-Keun","family":"On","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Cardiac Arrhythmia Center, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine , 81 Irwon-ro, Gangnam-gu, Seoul 06351 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7498-0705","authenticated-orcid":false,"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2025082907095467700_euaf150-B1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2025082907095467700_euaf150-B2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the Management of Atrial Fibrillation developed in collaboration with the European Association for Cardio-thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2025082907095467700_euaf150-B3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"key":"2025082907095467700_euaf150-B4","doi-asserted-by":"crossref","first-page":"e000302","DOI":"10.1136\/openhrt-2015-000302","article-title":"Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome","volume":"2","author":"Raine","year":"2015","journal-title":"Open Heart"},{"key":"2025082907095467700_euaf150-B5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont","year":"2014","journal-title":"Eur Heart J"},{"key":"2025082907095467700_euaf150-B6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","article-title":"Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic front (STOP AF) pivotal trial","volume":"61","author":"Packer","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025082907095467700_euaf150-B7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"2025082907095467700_euaf150-B8","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jacep.2018.07.007","article-title":"Single-procedure outcomes and quality-of-life improvement 12 months post-cryoballoon ablation in persistent atrial fibrillation: results from the multicenter CRYO4PERSISTENT AF trial","volume":"4","author":"Boveda","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2025082907095467700_euaf150-B9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N Engl J Med"},{"key":"2025082907095467700_euaf150-B10","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1161\/CIRCULATIONAHA.119.042622","article-title":"Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial","volume":"140","author":"Andrade","year":"2019","journal-title":"Circulation"},{"key":"2025082907095467700_euaf150-B11","doi-asserted-by":"crossref","first-page":"e010304","DOI":"10.1161\/CIRCEP.121.010304","article-title":"Arrhythmic burden and the risk of cardiovascular outcomes in patients with paroxysmal atrial fibrillation and cardiac implanted electronic devices","volume":"15","author":"Chew","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025082907095467700_euaf150-B12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2024.05.001","article-title":"Pulsed field vs conventional thermal ablation for paroxysmal atrial fibrillation: recurrent atrial arrhythmia burden","volume":"84","author":"Reddy","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2025082907095467700_euaf150-B13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/ehac692","article-title":"Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study","volume":"44","author":"Andrade","year":"2023","journal-title":"Eur Heart J"},{"key":"2025082907095467700_euaf150-B14","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.hrthm.2023.05.018","article-title":"Influence of monitoring and atrial arrhythmia burden on quality of life and health care utilization in patients undergoing pulsed field ablation: a secondary analysis of the PULSED AF trial","volume":"20","author":"Verma","year":"2023","journal-title":"Heart Rhythm"},{"key":"2025082907095467700_euaf150-B15","doi-asserted-by":"crossref","first-page":"euaf019","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"2025082907095467700_euaf150-B16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","article-title":"Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design","volume":"145","author":"Aguilar","year":"2022","journal-title":"Circulation"},{"key":"2025082907095467700_euaf150-B17","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jacep.2025.02.006","article-title":"Reduction of AF burden after cryoballoon ablation in patients with early persistent AF","volume":"11","author":"Lee","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2025082907095467700_euaf150-B18","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2016.03.005","article-title":"Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: results from the reveal LINQ usability study","volume":"13","author":"Sanders","year":"2016","journal-title":"Heart Rhythm"},{"key":"2025082907095467700_euaf150-B19","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.hrthm.2016.05.010","article-title":"Real-world performance of an enhanced atrial fibrillation detection algorithm in an insertable cardiac monitor","volume":"13","author":"Mittal","year":"2016","journal-title":"Heart Rhythm"},{"key":"2025082907095467700_euaf150-B20","doi-asserted-by":"crossref","first-page":"f312","DOI":"10.1093\/europace\/euy038","article-title":"Continuous monitoring after atrial fibrillation ablation: the LINQ AF study","volume":"20","author":"Wechselberger","year":"2018","journal-title":"Europace"},{"key":"2025082907095467700_euaf150-B21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"2025082907095467700_euaf150-B22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/europace\/euu342","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial","volume":"17","author":"Walfridsson","year":"2015","journal-title":"Europace"},{"key":"2025082907095467700_euaf150-B23","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.jacc.2020.04.065","article-title":"Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial","volume":"75","author":"Poole","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025082907095467700_euaf150-B24","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jacep.2020.04.017","article-title":"Quality of life and health care utilization in the CIRCA-DOSE study","volume":"6","author":"Andrade","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2025082907095467700_euaf150-B25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.hrthm.2019.10.014","article-title":"Sustained quality-of-life improvement post-cryoballoon ablation in patients with paroxysmal atrial fibrillation: results from the STOP-AF post-approval study","volume":"17","author":"Jain","year":"2020","journal-title":"Heart Rhythm"},{"key":"2025082907095467700_euaf150-B26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/eurheartj\/ehae580","article-title":"Radiofrequency catheter ablation of persistent atrial fibrillation by pulmonary vein isolation with or without left atrial posterior wall isolation: long-term outcomes of the CAPLA trial","volume":"46","author":"William","year":"2025","journal-title":"Eur Heart J"},{"key":"2025082907095467700_euaf150-B27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.2024.17921","article-title":"Pulmonary vein isolation vs sham intervention in symptomatic atrial fibrillation: the SHAM-PVI randomized clinical trial","volume":"332","author":"Dulai","year":"2024","journal-title":"JAMA"},{"key":"2025082907095467700_euaf150-B28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/pace.12389","article-title":"Atrial fibrillation burden estimates derived from intermittent rhythm monitoring are unreliable estimates of the true atrial fibrillation burden","volume":"37","author":"Charitos","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025082907095467700_euaf150-B29","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"2025082907095467700_euaf150-B30","doi-asserted-by":"crossref","first-page":"e2025473","DOI":"10.1001\/jamanetworkopen.2020.25473","article-title":"Association between quality of life and procedural outcome after catheter ablation for atrial fibrillation: a secondary analysis of a randomized clinical trial","volume":"3","author":"Terricabras","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025082907095467700_euaf150-B31","doi-asserted-by":"crossref","first-page":"euae104","DOI":"10.1093\/europace\/euae104","article-title":"Comprehensive atrial fibrillation burden and symptom reduction post-ablation: insights from DECAAF II","volume":"26","author":"Noujaim","year":"2024","journal-title":"Europace"},{"key":"2025082907095467700_euaf150-B32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12141","article-title":"Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study","volume":"24","author":"Kapa","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025082907095467700_euaf150-B33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/jce.12190","article-title":"Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation: an observational study through a subcutaneous leadless cardiac monitor","volume":"24","author":"Pedrote","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025082907095467700_euaf150-B34","doi-asserted-by":"crossref","first-page":"euae247","DOI":"10.1093\/europace\/euae247","article-title":"Smartphone app-based approximation of time spent with atrial fibrillation and symptoms in patients after catheter ablation: data from the TeleCheck-AF project","volume":"26","author":"Sandgren","year":"2024","journal-title":"Europace"},{"key":"2025082907095467700_euaf150-B35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2025082907095467700_euaf150-B36","first-page":"1211","article-title":"Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial","volume":"29","author":"Mantovan","year":"2013","journal-title":"Can J Cardiol"},{"key":"2025082907095467700_euaf150-B37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamacardio.2021.3063","article-title":"Association of atrial fibrillation burden with health-related quality of life after atrial fibrillation ablation: substudy of the cryoballoon vs contact-force atrial fibrillation ablation (CIRCA-DOSE) randomized clinical trial","volume":"6","author":"Samuel","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2025082907095467700_euaf150-B38","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jacc.2023.06.029","article-title":"Ablation to reduce atrial fibrillation burden and improve outcomes. JACC review topic of the week","volume":"82","author":"Schwennesen","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025082907095467700_euaf150-B39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCOUTCOMES.114.001303","article-title":"Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF)","volume":"8","author":"Freeman","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025082907095467700_euaf150-B40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jacep.2017.06.007","article-title":"Symptoms and quality of life after atrial fibrillation ablation: two different concepts","volume":"3","author":"Dorian","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2025082907095467700_euaf150-B41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.125.074485","article-title":"Pulsed field ablation of persistent atrial fibrillation with continuous ECG monitoring follow-up: ADVANTAGE AF-phase 2","volume":"152","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"2025082907095467700_euaf150-B42","doi-asserted-by":"crossref","first-page":"euad244","DOI":"10.1093\/europace\/euad244","article-title":"Progress in atrial fibrillation ablation during 25 years of Europace journal","volume":"25","author":"Boersma","year":"2023","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/8\/euaf150\/64160514\/euaf150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/8\/euaf150\/64160514\/euaf150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T11:10:02Z","timestamp":1756465802000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euaf150\/8243878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaf150","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8]]},"article-number":"euaf150"}}